788 related articles for article (PubMed ID: 26435097)
1. Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis.
Nagatomo Y; Tang WH
J Card Fail; 2015 Dec; 21(12):973-80. PubMed ID: 26435097
[TBL] [Abstract][Full Text] [Related]
2. Exploring the Microbiome in Heart Failure.
Kitai T; Kirsop J; Tang WH
Curr Heart Fail Rep; 2016 Apr; 13(2):103-9. PubMed ID: 26886380
[TBL] [Abstract][Full Text] [Related]
3. TMAO: how gut microbiota contributes to heart failure.
Zhang Y; Wang Y; Ke B; Du J
Transl Res; 2021 Feb; 228():109-125. PubMed ID: 32841736
[TBL] [Abstract][Full Text] [Related]
4. Gut Microbiota Composition and Cardiovascular Disease: A Potential New Therapeutic Target?
Belli M; Barone L; Longo S; Prandi FR; Lecis D; Mollace R; Margonato D; Muscoli S; Sergi D; Federici M; Barillà F
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569352
[TBL] [Abstract][Full Text] [Related]
5. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A
J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824
[TBL] [Abstract][Full Text] [Related]
6. Dietary metabolism, the gut microbiome, and heart failure.
Tang WHW; Li DY; Hazen SL
Nat Rev Cardiol; 2019 Mar; 16(3):137-154. PubMed ID: 30410105
[TBL] [Abstract][Full Text] [Related]
7. Impact of intestinal microbiota in patients with heart failure: A systematic review.
Formiga F; Ferreira Teles CI; Chivite D
Med Clin (Barc); 2019 Nov; 153(10):402-409. PubMed ID: 31416611
[TBL] [Abstract][Full Text] [Related]
8. The Gut Axis Involvement in Heart Failure: Focus on Trimethylamine N-oxide.
Salzano A; Cassambai S; Yazaki Y; Israr MZ; Bernieh D; Wong M; Suzuki T
Heart Fail Clin; 2020 Jan; 16(1):23-31. PubMed ID: 31735312
[TBL] [Abstract][Full Text] [Related]
9. Gut Microbiome and Precision Nutrition in Heart Failure: Hype or Hope?
Chaikijurajai T; Tang WHW
Curr Heart Fail Rep; 2021 Apr; 18(2):23-32. PubMed ID: 33559845
[TBL] [Abstract][Full Text] [Related]
10. Modulation of Gut Microbiota-Brain Axis by Probiotics, Prebiotics, and Diet.
Liu X; Cao S; Zhang X
J Agric Food Chem; 2015 Sep; 63(36):7885-95. PubMed ID: 26306709
[TBL] [Abstract][Full Text] [Related]
11. Targeting the human microbiome and its metabolite TMAO in cardiovascular prevention and therapy.
Dannenberg L; Zikeli D; Benkhoff M; Ahlbrecht S; Kelm M; Levkau B; Polzin A
Pharmacol Ther; 2020 Sep; 213():107584. PubMed ID: 32446759
[TBL] [Abstract][Full Text] [Related]
12. Current understanding of gut microbiota alterations and related therapeutic intervention strategies in heart failure.
Chen X; Li HY; Hu XM; Zhang Y; Zhang SY
Chin Med J (Engl); 2019 Aug; 132(15):1843-1855. PubMed ID: 31306229
[TBL] [Abstract][Full Text] [Related]
13. Trimethylamine N-oxide (TMAO) as a New Potential Therapeutic Target for Insulin Resistance and Cancer.
Oellgaard J; Winther SA; Hansen TS; Rossing P; von Scholten BJ
Curr Pharm Des; 2017; 23(25):3699-3712. PubMed ID: 28641532
[TBL] [Abstract][Full Text] [Related]
14. Nonlethal Inhibition of Gut Microbial Trimethylamine N-oxide Production Improves Cardiac Function and Remodeling in a Murine Model of Heart Failure.
Organ CL; Li Z; Sharp TE; Polhemus DJ; Gupta N; Goodchild TT; Tang WHW; Hazen SL; Lefer DJ
J Am Heart Assoc; 2020 May; 9(10):e016223. PubMed ID: 32390485
[TBL] [Abstract][Full Text] [Related]
15. The role of the microbiome for human health: from basic science to clinical applications.
Mohajeri MH; Brummer RJM; Rastall RA; Weersma RK; Harmsen HJM; Faas M; Eggersdorfer M
Eur J Nutr; 2018 May; 57(Suppl 1):1-14. PubMed ID: 29748817
[TBL] [Abstract][Full Text] [Related]
16. The gut microbiome, diet, and links to cardiometabolic and chronic disorders.
Aron-Wisnewsky J; Clément K
Nat Rev Nephrol; 2016 Mar; 12(3):169-81. PubMed ID: 26616538
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiome - A potential mediator of pathogenesis in heart failure and its comorbidities: State-of-the-art review.
Mamic P; Chaikijurajai T; Tang WHW
J Mol Cell Cardiol; 2021 Mar; 152():105-117. PubMed ID: 33307092
[TBL] [Abstract][Full Text] [Related]
18. Soluble Dietary Fiber Reduces Trimethylamine Metabolism via Gut Microbiota and Co-Regulates Host AMPK Pathways.
Li Q; Wu T; Liu R; Zhang M; Wang R
Mol Nutr Food Res; 2017 Dec; 61(12):. PubMed ID: 28884952
[TBL] [Abstract][Full Text] [Related]
19. Role and Effective Therapeutic Target of Gut Microbiota in Heart Failure.
Jia Q; Li H; Zhou H; Zhang X; Zhang A; Xie Y; Li Y; Lv S; Zhang J
Cardiovasc Ther; 2019; 2019():5164298. PubMed ID: 31819762
[TBL] [Abstract][Full Text] [Related]
20. Role of the intestinal microbiome and its therapeutic intervention in cardiovascular disorder.
Luqman A; Hassan A; Ullah M; Naseem S; Ullah M; Zhang L; Din AU; Ullah K; Ahmad W; Wang G
Front Immunol; 2024; 15():1321395. PubMed ID: 38343539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]